These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6300701)

  • 1. [Hepatitis during the administration of ketoconazole (Nizoral)].
    van Dijke CP
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):339-41. PubMed ID: 6300701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxic hepatitis during the administration of ketoconazole (Nizoral)].
    Kramer NJ; Montnor LP; Berghuis PH
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):343-4. PubMed ID: 6300703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxic hepatitis caused by ketoconazole (Nizoral)].
    Boëtius G; Peeters JP; Peters JH
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):341-3. PubMed ID: 6300702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxic hepatitis caused by ketoconazole].
    Ned Tijdschr Geneeskd; 1983 Jun; 127(25):1114-5. PubMed ID: 6308481
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ketoconazole--a change in antimycotic therapy?].
    Meinhof W
    Hautarzt; 1983 Apr; 34(4):155-8. PubMed ID: 6303982
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis and ketoconazole therapy.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1058-9. PubMed ID: 6271330
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hepatitis during ketoconazole therapy.
    Okumura H; Aramaki T; Satomura K; Iizuka K; Ohta M; Katsuta Y; Akaike M; Terada H; Kusunoki T
    Gastroenterol Jpn; 1983 Apr; 18(2):142-7. PubMed ID: 6303886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
    Tkach JR; Rinaldi MG
    Cutis; 1982 May; 29(5):482-4. PubMed ID: 6284445
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic dysfunction and ketoconazole therapy.
    Svejgaard E; Ranek L
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):788-9. PubMed ID: 6283980
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxic hepatis during ketoconazole treatment.
    Heiberg JK; Svejgaard E
    Br Med J (Clin Res Ed); 1981 Sep; 283(6295):825-6. PubMed ID: 6271328
    [No Abstract]   [Full Text] [Related]  

  • 11. Ketoconazole and hepatic reactions.
    Boughton K
    S Afr Med J; 1983 Jun; 63(25):955. PubMed ID: 6304923
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketoconazole: assessing its risks.
    Stern RS
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):544. PubMed ID: 6281317
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic toxicity of ketoconazole.
    Rollman O; Lööf L
    Br J Dermatol; 1983 Mar; 108(3):376-8. PubMed ID: 6299322
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoconazole-induced hepatotoxicity.
    Bernuau J; Durand F; Pessayre D
    Hepatology; 1997 Sep; 26(3):802. PubMed ID: 9303518
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential and problems with ketoconazole.
    Graybill JR
    Am J Med; 1983 Jan; 74(1B):86-90. PubMed ID: 6295157
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study.
    Chien RN; Yang LJ; Lin PY; Liaw YF
    Hepatology; 1997 Jan; 25(1):103-7. PubMed ID: 8985273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute hepatocytic necrosis during ketoconazole therapy for treatment of onychomycosis. National Foundation for Registry and Evaluation of Adverse Effects].
    Van Puijenbroek EP; Metselaar HJ; Berghuis PH; Zondervan PE; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2416-8. PubMed ID: 9864540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
    Horsburgh CR; Kirkpatrick CH
    Am J Med; 1983 Jan; 74(1B):23-9. PubMed ID: 6295149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses.
    Jolly HW; Daily AD; Rex IH; Krupp I; Tromovitch TA; Stegman SJ; Glogau R
    Cutis; 1983 Feb; 31(2):208-10, 212-3 passim. PubMed ID: 6299652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin and nail mycoses: treatment with ketoconazole, a new oral antimycotic agent.
    Botter AA; Dethier F; Mertens RL; Morias J; Peremans W
    Mykosen; 1979 Aug; 22(8):274-8. PubMed ID: 161994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.